Up-regulation of LPA receptors are observed in breast cancer and activation of MAPK and phosphatidylinositol 3-kinase (PI3K)/AKT pathways by LPA are implicated in breast cancer development and progression [30], [31]. Here, LPA is linked to breast carcinoma.